Roger Pomerantz, President and CEO at Seres Therapeutics, Inc. (MCRB), sold 52,776 shares at $29.27 ($1.5M) on 2016-07-05, disclosed to the SEC on 2016-07-07.
Open-market sale of $1.5M MCRB by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.27 | 49,871 | $1.5M | 94.4% |
| 2 | $29.96 | 2,905 | $87K | 5.6% |
| Total | $29.31 avg | 52,776 | $1.5M | 100% |
| Filing → |
| RUBY | BUY | 2018-07-23 | $2K | — | Filing → |
| MCRB | SELL | 2018-07-12 | $9K | — | Filing → |
| MCRB | SELL | 2018-07-10 | $590K | — | Filing → |